Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cereno Scientific reports positive Phase I PK-bridging results for CS014, backs direct move to Phase IIb in PH-ILD

Cereno Scientific reports positive Phase I PK-bridging results for CS014, backs direct move to Phase IIb in PH-ILD

BitgetBitget2026/09/25 08:15
  • Cereno Scientific reported positive topline results from a Phase I pharmacokinetic bridging study of HDAC inhibitor CS014.
  • Results have been presented as topline data; fuller findings are slated for publication in 2027.
  • Study supported the planned regulatory strategy to move CS014 directly into Phase IIb in PH-ILD, pending FDA review.
  • Safety profile was consistent with prior Phase I experience, with mild adverse events and no serious events.
  • IND submission is planned for Q4 2026; Phase IIb start is targeted for Q3 2027, subject to regulatory clearance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cereno Scientific AB published the original content used to generate this news brief on September 25, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Federal Reserve official turns hawkish again, Goolsbee: Inflation remains high, does not rule out the possibility of an unusually large rate hike

Chicago Fed President Austan Goolsbee said on Thursday that inflation readings have remained persistently high in recent months, with almost no progress in areas where improvement had been expected. He stated that all policy options are on the table for next month's Federal Reserve meeting, and did not rule out the possibility of a rate hike exceeding the usual magnitude.

华尔街见闻•2026/11/19 22:26

Meta plans to launch the AI device Muse Charm priced at $300, with its smartwatch postponed until 2027.

According to media reports, Meta plans to price the Muse Charm at $300, including 12 months of free 5G service, and will offer subsidies to lower the purchase threshold for users. The Muse Charm is a compact device equipped with a screen and built-in 5G capabilities, allowing users to access Meta’s AI assistant Muse anytime without relying on Wi-Fi or carrying a smartphone. Mark Zuckerberg previously stated that the Muse Charm is scheduled to launch during the December holiday shopping season.

华尔街见闻•2026/11/19 22:23
Meta plans to launch the AI device Muse Charm priced at $300, with its smartwatch postponed until 2027.